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Tyrosine Phosphatase STEP Is a Tonic Brake
on Induction of Long-Term Potentiation
(Huang et al., 2001; Lu et al., 1998). Thus, tyrosine phos-
phorylation has emerged as a key regulator of NMDAR
function and thereby of excitatory synaptic trans-
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The level of tyrosine phosphorylation of NMDARs is,1Department of Physiology
2 Programme in Brain and Behaviour however, not determined by Src alone but by the balance
between its activity and that of a phosphotyrosine phos-Hospital for Sick Children
3 Institute of Medical Science phatase (PTP). The endogenous PTP regulating the
function of NMDARs is known to be intimately associ-University of Toronto
Toronto Ontario, M5G 1X8 ated with the receptor (Wang et al., 1996) but the identity
of this PTP has remained elusive. PTPs are a large,Canada
4 The Child Study Center structurally diverse superfamily of enzymes which may
have exquisite specificity of their effects in cells (TonksYale University School of Medicine
New Haven, Connecticut 06520 and Neel, 2001). A number of PTPs have been shown
to be expressed in the CNS, the majority of which are
receptor-type PTPs, which have been implicated in neu-
ronal morphogenesis, neural development, and axonSummary
guidance (Arregui et al., 2000; Naegele and Lombroso,
1994; Stoker and Dutta, 1998; Stoker, 2001). The levelThe functional roles of protein tyrosine phosphatases
(PTPs) in the developed CNS have been enigmatic. of expression of such PTPs typically is dramatically
downregulated during ontogeny, making these unlikelyHere we show that striatal enriched tyrosine phospha-
tase (STEP) is a component of the N-methyl-D-aspar- candidates for the PTP regulating NMDARs, which is
expressed in adult neurons. One family of PTPs whosetate receptor (NMDAR) complex. Functionally, exoge-
nous STEP depressed NMDAR single-channel activity expression level is high in the adult is the striatal en-
riched phosphatase (STEP) family. STEPs are brain-spe-in excised membrane patches. STEP also depressed
NMDAR-mediated synaptic currents whereas inhib- cific, nonreceptor-type PTPs that were originally identi-
fied as highly enriched within neurons of the striatumiting endogenous STEP enhanced these currents. In
hippocampal slices, administering STEP into CA1 neu- (Lombroso et al., 1991, 1993), although more extensive
mapping studies found them in multiple brain regionsrons did not affect basal glutamatergic transmission
evoked by Schaffer collateral stimulation but pre- including the hippocampus and cerebral cortex (Bou-
langer et al., 1995). STEP immunoreactivity has beenvented tetanus-induced long-term potentiation (LTP).
Conversely, inhibiting STEP in CA1 neurons enhanced observed in postsynaptic densities (Oyama et al., 1995),
raising the possibility that this PTP might postsynapti-transmission and occluded LTP induction through an
NMDAR-, Src-, and Ca2-dependent mechanism. Thus, cally modulate glutamatergic transmission. In the pres-
ent study, we investigated whether STEP regulatesSTEP acts as a tonic brake on synaptic transmission
by opposing Src-dependent upregulation of NMDARs. NMDAR function in opposition to Src at excitatory syn-
apses.
Introduction
Fast excitatory synaptic transmission within the mam- Results
malian central nervous system (CNS) is principally medi-
ated by the transmitter glutamate acting at postsynaptic STEP Is a Component of the NMDAR Complex
Studies on spinal cord neurons first demonstrated thatAMPA and NMDA subtypes of ionotropic glutamate
receptors (Edmonds et al., 1995; Hollmann and Heine- the PTP opposing Src is intimately associated with the
mann, 1994). Activation of the NMDA subtype of gluta- NMDAR complex (Wang et al., 1996) . We therefore used
mate receptor is crucial for development, neuroplastic- homogenates from the spinal cord to determine if STEP
ity, and excitotoxicity in the CNS (Dingledine et al., 1999; associates with NMDARs. We found that STEP61, the
McBain and Mayer, 1994). The function of NMDA recep- highest molecular weight isoform of the STEP family
tors (NMDARs) is dynamically tuned to the state of the (Boulanger et al., 1995), was expressed in the spinal
neuron by intracellular biochemical processes, including cord (Figure 1A). In order to determine whether STEP
tyrosine phosphorylation/dephosphorylation (Wang and and NMDA channels are associated physically, we im-
Salter, 1994). NMDAR function is upregulated by the munoprecipitated membrane proteins with monoclonal
nonreceptor tyrosine kinase Src (Yu et al., 1997), which antibodies specifically directed against STEP (anti-
serves as a point of convergence through which signal- STEP; Boulanger et al., 1995) or NR1, a requisite subunit
ing cascades modulate NMDAR function (Huang et al., of NMDARs (Dingledine et al., 1999). We used non-dena-
2001; Lu et al., 1999) and is required for NMDAR-depen- turing conditions to solubilize membrane proteins from
dent long-term potentiation (LTP) in the hippocampus spinal cord homogenates and found that immunopreci-
pitating with anti-STEP led to co-precipitation of NR1
(Figure 1A). Conversely, immunoprecipitation with anti-5 Correspondence: mike.salter@utoronto.ca
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Figure 1. STEP Associates with NMDARs
(A) In the left panel, immunoblot analysis of spinal cord homogenates (Hom) and solubilized membranes (SM) with anti-STEP antibody revealed
a protein band of approximately 61 kDa. Striatal homogenates (Hom) and crude synaptosomes (CS) probed as positive controls contained the
same immunopositive band as well as other lower molecular weight STEP isoforms. The right panels depict representative immunoprecipitation
experiments from spinal cord membranes with anti-STEP (upper panel), anti-NR1 (lower panel), or nonspecific IgG (both panels) under
nondenaturing conditions. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and analyzed by sequential immunoblotting
with anti-NR1 (upper panel), or anti-STEP (lower panel).
(B) The left panel shows an immunoblot analysis of striatal and hippocampal homogenates (Hom) probed with anti-STEP. The middle panel
shows an immunoblot probed with anti-STEP of proteins coimmunoprecipitating with anti-NR1 from hippocampal homogenates (left lane,
anti-NR1). In the right lane, the anti-NR1 antibody was run to show the position of the IgG heavy chain (IgG). The right panel displays an
immunoblot probed with anti-NR1 antibody of proteins co-precipitating with anti-STEP from hippocampal homogenates (left lane, anti-STEP).
In the right lane, the immunoprecipitation was performed using nonspecific IgG. In both (A) and (B), co-precipitation of STEP by anti-NR1 and
of NR1 by anti-STEP was prevented when denaturing solubilization conditions were used, whereas the immunoprecipitation of NR1 or STEP
by the corresponding antibodies was not affected (data not shown).
(C) shows a representative immunoblot probed with anti-STEP antibody (upper panel) of proteins coimmunoprecipitating with anti-GluR2 or
nonspecific IgG from hippocampal homogenates (middle and right lanes, respectively). The blot was stripped and reprobed with anti-GluR2
(lower panel). The starting homogenate was run in the left lane (Input).
NR1 co-precipitated STEP61 (Figure 1A). Neither NR1 nor Administering STEP Reduces NMDA Single-
Channel Activity and NMDAR-MediatedSTEP61 was precipitated by nonspecific IgG. Because
NMDARs in hippocampal neurons are also regulated by Synaptic Currents
Inhibiting Src, thereby allowing the unopposed actiontyrosine phosphorylation, we examined STEP expres-
sion and association with NMDARs in the hippocampus. of the endogenous PTP, depresses NMDA channel gat-
ing by decreasing mean channel open time (to) and openAs with the spinal cord, we found that the major STEP
isoform expressed in the hippocampus is STEP61 (Figure probability (Po), and causes characteristic changes in
channel kinetics (Yu et al., 1997). To determine whether1B). Immunoprecipitating with anti-NR1 led to co-pre-
cipitation of STEP61 from hippocampal homogenates, STEP downregulates NMDA channel gating, we re-
corded NMDAR-mediated single-channel currents us-and immunoprecipitation with anti-STEP co-precipi-
tated NR1 (Figure 1B). From these data together, we ing inside-out patches excised from spinal cord neu-
rons. We found that applying purified, recombinantconcluded that STEP61 and NMDAR subunit proteins
associate, directly or indirectly, in vitro. Therefore, STEP to the cytoplasmic face of the patches depressed
channel activity without altering single-channel conduc-STEP61 may be a component of the NMDAR complex in
situ and thus may be strategically positioned to regulate tance (Figure 2A). On average, Po decreased to 46% 
7.4% of that during the control period just prior toNMDAR function. In contrast, STEP did not co-precipi-
tate with the AMPA receptor subunit GluR2 (Figure 1C), applying STEP and there was a reduction in to to 71%
7.3% of control (mean  SEM; n  5 patches). STEPindicating that STEP may interact selectively with
NMDARs but not with AMPARs. also caused marked changes in the distributions of open
PTP STEP Is a Tonic Brake on LTP Induction
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Figure 2. Recombinant STEP Depresses NMDAR Activity
(A1) A continuous record of NMDA channel open probability (Po) before and during application of recombinant STEP to the cytoplasmic face
of a membrane patch is shown. Po was calculated in bins of 10s in duration.
(A2) Continuous sample traces of currents from the same patch used in (A1) obtained before (left set of traces) and during STEP (5 g/ml;
right set of traces) application are shown (calibration bars are 100 ms/3 pA).
(A3) Dwell-time histograms of open and shut times before (upper panels) and during (lower panels) STEP application are shown. Dashed lines
indicate the individual exponential components of the open and shut times and solid lines show the sum of the components. The average
time constants of the individual exponential components before STEP application were (mean  SEM) 0.10  0.02, 1.3  0.24, and 5.6 
0.24 ms (open times) and 0.14  0.03, 0.8  0.07, 13.0  1.9, 226  119, and 1449  876 ms (closed times); these time constants were not
significantly altered by STEP application.
(A4) A bar graph summarizing the effects of STEP on single channel parameters is shown (n  5 patches). Values are the means  SEM. Po,
open probability; to, mean open time; B, burst duration; C, cluster duration; SC, supercluster duration. (*p  0.05, paired t test before versus
during STEP.)
(B1) Traces of representative averaged mEPSCs (top traces) or NMDA components (INMDA) (lower traces) obtained from 0–2 min or from 10–20
min after breakthrough with recombinant STEP in the recording pipette are shown. We constructed INMDA by subtracting, from the averaged
mEPSC, a current decaying at a single exponential rate equal to the fast component. Scale bars for mEPSCs are 50 ms/5 pA and for INMDA
are 50 ms/1 pA.
(B2) The mean changes in the NMDA and AMPA components of averaged mEPSCs recorded at 10–20 min after breakthrough are expressed
as a percentage of control mEPSCs obtained 0–2 min after breakthrough during recordings with regular intracellular solution (ICS; n  8 cells)
or ICS supplemented with recombinant STEP (n  6 cells). Peak mEPSC amplitude was measured to determine the AMPA component of
averaged mEPSCs and integrated current during INMDA (charge) was measured to determine the NMDA component of averaged mEPSCs.
(**p  0.01; t test versus ICS.)
and shut times, changes which were due to alterations ure 2A4) and in the total open time and number of open-
ings during the bursts (not illustrated). Thus, the effectsin the relative weighting of the components rather than
to significant changes in the values of the time constant of STEP were similar to those predicted for the endoge-
nous PTP.for each component. STEP caused an increase in the
area of the shortest open time and longest shut time Because the kinetic properties of NMDA channels
shape synaptic NMDAR-mediated responses (Edmondswith concomitant decreases in the area of the longest
open times and shortest closed times (Figure 2A3). STEP et al., 1995), we predicted that STEP would depress
NMDAR synaptic currents. We therefore studied the ef-also produced a decrease in the duration of bursts (Fig-
Neuron
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Figure 3. Synaptic NMDARs Are Tonically Inhibited by Endogenous STEP
(A1–B1) Representative averaged mEPSCs (top traces) or NMDA components (INMDA) (lower traces) obtained from 0–2 min or from 10–20 min
after breakthrough with anti-STEP (A1) or c300S STEP (B1) in the recording pipette are displayed. In (A1), APV (50 M) was added to the
bathing solution at the end of the experiment to demonstrate that the late component of the mEPSC is mediated by NMDAR activation. Scale
bars for mEPSCs are 50 ms/5 pA and for INMDA are 50 ms/1 pA. (A2–B2) Mean changes in the NMDA and AMPA components of averaged
mEPSCs recorded at 10–20 min after breakthrough are expressed as a percentage of control mEPSCs obtained 0–2 min after breakthrough
during recordings with ICS (n  8 cells) or ICS supplemented with anti-STEP (A2; n  7 cells), nonspecific IgG (A2; n  5 cells), or C300S
STEP (B2; n  6 cells) (**p  0.01, *p  0.05; t test versus ICS; for anti-STEP versus IgG in (A2), p  0.05). The inset in (A2) shows a
representative phosphatase activity assay for recombinant STEP (left panel) and T cell phosphatase (right panel) in the absence (• both panels)
and presence ( both panels) of anti-STEP or nonspecific IgG (H17009 left panel only). The concentrations of STEP and T cell PTP are in pmol. In
(B2), the effect of STEP is replotted for comparison with C300S STEP.
fects of STEP on miniature excitatory postsynaptic cur- inhibiting Src (Yu et al., 1997), indicating that depression
of NMDAR function by STEP resembles that induced byrents (mEPSCs) during whole-cell recordings from cul-
tured dorsal horn neurons (Figure 2B). Administering the endogenous PTP. To test whether this endogenous
PTP is STEP, we intracellularly applied the anti-STEPrecombinant STEP intracellularly through the recording
pipette led to a decline in the NMDAR-mediated compo- antibody (Boulanger et al., 1995). In PTP activity assays,
we found that this antibody inhibited the function ofnent of the mEPSCs: on average the NMDAR-mediated
component of mEPSCs recorded 10–20 min after the recombinant STEP but did not affect the activity of puri-
fied T cell phosphatase catalytic domain (inset Figurestart of recording was reduced to 56%  8% of the
initial value during the first 2 min of recording (n  7 3A) or of recombinant PTP-1B (see Experimental Proce-
dures). Thus, the anti-STEP antibody inhibits STEP func-cells). In contrast to the effect of STEP on the NMDAR
component of mEPSCs, STEP produced no effect on the tion but is not a general PTP inhibitor. The anti-STEP
antibody was found to increase the NMDAR-mediatedAMPAR-mediated component. Thus, STEP selectively
depressed NMDARs, but not AMPARs, at synapses. component of mEPSCs to 141% 9% of the initial level
in dorsal horn neurons (n  7 cells; Figure 3A). On the
other hand, a nonspecific IgG antibody did not signifi-Endogenous STEP Tonically Depresses NMDAR
Function in Opposition to Src cantly alter the NMDAR component of the mEPSCs (n
6 cells). Neither the anti-STEP antibody nor nonspecificThe effects of STEP on NMDAR single-channel kinetics
and NMDAR mEPSCs were similar to those caused by IgG affected the AMPAR-mediated component of the
PTP STEP Is a Tonic Brake on LTP Induction
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mEPSCs. As an independent test to determine the effect
of inhibiting endogenous STEP, we intracellularly admin-
istered a dominant-negative mutant STEP (C300S STEP)
(Lombroso et al., 1993) (Figure 3B). Including C300S
STEP in the recording pipette led to an increase in the
NMDAR-component of mEPSCs; the AMPAR-compo-
nent of the mEPSCs was unaffected by C300S STEP
(Figure 3B).
In CA1 pyramidal neurons recorded from acute hippo-
campal slices, we found that intracellularly administered
anti-STEP increased the amplitude of pharmacologically
isolated NMDAR EPSCs evoked by Schaffer collateral
stimulation (Figure 4A): 20 min into recordings, NMDAR-
mediated EPSCs were 184% 31% (n  5) of the initial
level when anti-STEP was intracellularly administered
as compared with 106%  12% (n  6) in controls
without anti-STEP (p 0.05) or 92% 15% (n 5) with
administration of nonspecific IgG (p0.05). Importantly,
the current-voltage relationship of the NMDAR EPSCs
after potentiation by anti-STEP was not different from
that of control or IgG recordings (Figure 4B) and there-
fore, the upregulation of NMDAR function by inhibiting
STEP does not alter depression of NMDARs by extracel-
lular Mg2. Taken together these results indicate that in
dorsal horn and CA1 neurons there is ongoing suppres-
sion of the function of synaptic NMDARs by endogenous
STEP.
If the ongoing depression of NMDARs by STEP di-
rectly opposes Src then blocking this kinase is predicted
to occlude the effect of exogenously administering
STEP. We tested this prediction using dorsal horn neu-
rons which were pre-treated with the Src kinase inhibitor
PP2 (Hanke et al., 1996) in order to depress NMDAR
currents prior to recording (Figure 5). STEP, adminis-
tered intracellularly in the continued presence of PP2,
did not further depress the NMDAR-mediated compo-
nent of mEPSCs (Figures 5A and 5C). Conversely, in the
Figure 4. STEP Inhibition Potentiates NMDAR-Mediated EPSCs inpresence of PP3, an inactive analog of PP2, intracellular
Hippocampal Neurons without Altering Voltage-Dependent Mg2application of STEP depressed the NMDAR-component
Inhibition
of the mEPSCs (Figures 5B and 5C), and the extent of
(A) The upper panel displays scatter plots of the normalized NMDA
the depression was not different from that produced by EPSC peak amplitude for representative cells recorded with control
STEP alone (cf. Figure 2B). If Src and STEP act recipro- ICS (), or with ICS supplemented with anti-STEP ICS () or with
cally, it is further predicted that inhibiting Src will prevent nonspecific IgG (). The traces at right are the average of six consec-
utive EPSCs obtained at the times indicated (Scale bars are 50 ms/the upregulation of NMDARs caused by anti-STEP. Con-
50 pA). The lower panel is a plot of the average NMDAR EPSCsistent with this prediction, we found that applying PP2
amplitude versus time for experiments performed with anti-STEPprevented the increase in the NMDAR-component of
supplemented ICS (, n  5), control ICS (, n  6), or nonspecific
the mESPCs by anti-STEP; PP3 did not affect the anti- IgG supplemented ICS (, n  5).
STEP-induced increase in NMDAR mEPSCs (Figure 5C). (B) The current-voltage (I-V) relationships for pharmacologically iso-
Thus, the effects of applying exogenous STEP or of lated NMDAR EPSCs during intracellular administration of anti-STEP
(, n  5), control solution (, n  5), or nonspecific IgG (, n inhibiting endogenous STEP are prevented by blocking
4) are plotted. I-V relationships for individual cells were obtained atSrc. These findings indicate that STEP opposes the ef-
the end of the recording period 20 min after breakthrough, and thefect of Src on NMDARs. Since the STEP isoform which
peak amplitude of the EPSCs obtained at holding potentials from
is part of the NMDAR complex is STEP61, we conclude 80 to60 were normalized to that at40 mV. On the right superim-
that STEP61 is the PTP that opposes Src in the regulation posed NMDAR EPSC traces at membrane potentials from 80
of NMDARs. to 40 mV are shown in steps of 20 mV for three representative
cells (scale bars are 100 ms/200 pA).
Administering STEP Prevents
Tetanus-Induced LTP
Activation of Src in the CA1 region of the hippocampus effect of Src on NMDAR function, associates with hippo-
campal NMDARs, and regulates NMDARs at Schafferis produced by tetanic stimulation of Schaffer collateral
inputs and is required postsynaptically for induction of collateral-CA1 synapses, we questioned whether STEP
may participate in synaptic plasticity in CA1 neurons.long-term potentiation (LTP) at Schaffer collateral-CA1
synapses (Lu et al., 1998). Because STEP opposes the We used whole-cell recordings from CA1 neurons in
Neuron
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Figure 5. Regulation of NMDAR Currents by STEP Requires Endogenous Src Kinase Activity
(A) Traces are representative averaged mEPSCs obtained from 0–2 min after breakthrough or 10–20 min after breakthrough with STEP in the
recording pipette in the presence of PP2 (upper panel) or PP3 (lower panel) containing extracellular solution. Scale bars are for both sets of
traces and are 50 ms/5 pA.
(B) Mean changes in the NMDA and AMPA component of mEPSCs in the presence of PP2 (black bars) or PP3 (gray bars) with ICS (n  6 for
PP2 and 5 for PP3), STEP (n  4 for PP2 and 4 for PP3), or anti-STEP (n  6 for PP2 and 5 for PP3) in the recording pipette are depicted.
(*p  0.05, t test versus ICS.)
acute hippocampal slices to administer STEP postsyn- the recording electrode resulted in a progressive in-
crease in EPSPs to 189%  14% of the initial level 20aptically and simultaneously recorded field potentials.
STEP was found to have no effect on baseline excitatory min into the recording (p  0.05; n  4 cells; Figure 8B).
Conversely, in cells recorded with control intracellularpostsynaptic potentials (EPSPs) at these synapses (n
6 cells; Figure 6). Tetanic stimulation of the Schaffer solution lacking anti-STEP or C300S STEP (Figures 6B,
7B, and 8B), baseline EPSPs did not change during thecollateral inputs produced post-tetanic potentiation in
neurons in which exogenous STEP was applied, but pre-tetanus period of recording and Schaffer collateral
tetanus induced a persistent increase in EPSPs (176%over the subsequent 30 min, the EPSPs returned to the
level prior to tetanus: EPSP slope was 103%  11% 22%; p  0.01). Thus, inhibiting STEP caused a sus-
tained potentiation of EPSPs which occluded induction(p  0.5) of the pre-tetanus level 30 min after tetanus.
On the other hand, in the field recordings from these of LTP.
slices and also in control whole-cell recordings without
exogenous STEP (n  8), tetanic stimulation produced Enhancement of EPSPs by Inhibiting STEP Is
post-tetanic potentiation and also a lasting increase in NMDAR, Src, and Ca2 Dependent
EPSPs which persisted throughout the recording period The EPSPs in CA1 neurons are primarily mediated by
(Figure 6). Thus, administering STEP into CA1 neurons AMPARs, which are not directly regulated by tyrosine
prevented the induction of LTP by tetanic stimulation phosphorylation/dephosphorylation (Huang et al., 2001;
of Schaffer collaterals. Lu et al., 1998; O’Dell et al., 1991) . We therefore pre-
dicted that the upregulation of CA1 EPSPs observed
during intracellular administration of anti-STEP wouldInhibiting Endogenous STEP Enhances EPSPs
and Occludes Tetanus-Induced LTP require NMDAR activity. During NMDAR blockade, with
bath application of the noncompetitive NMDAR antago-We next investigated the role of endogenous STEP in
synaptic transmission and plasticity in CA1 neurons by nist MK801, we found that administering anti-STEP in-
tracellularly caused no change in EPSP slope: EPSPadministering anti-STEP intracellularly during whole-cell
recordings (Figure 7). Anti-STEP produced a progressive slope was 105%  6.6% (p  0.5; n  4 cells) of the
initial level after 20 min of whole-cell recording (Figuresincrease in EPSPs over the first 20 min of recording
reaching a level of 181%  18% of the initial level (p  8A and 8B). Furthermore, the increase in EPSP slope
produced by anti-STEP was prevented when a peptide,0.01; n  9 cells). Subsequent tetanic stimulation of the
Schaffer collateral input caused a transient post-tetanic Src40-58, which prevents Src-induced enhancement of
NMDARs (Yu et al., 1997), was co-administered withpotentiation of the EPSPs but no lasting increase as
compared with the period just prior to tetanus: 30 min anti-STEP through the recording electrode (Figures 8A
and 8B). Lastly, we determined whether the enhance-after tetanus EPSP slope was on average 100%  14%
(p 0.5) of the level just prior to tetanus, whereas fEPSP ment of AMPAR EPSPs caused by inhibiting STEP de-
pended upon raising intracellular Ca2. We found thatslope increased to 138%  7% (p  0.01). Similarly,
introduction of C300S STEP into CA1 neurons through when the buffering capacity of the intracellular environ-
PTP STEP Is a Tonic Brake on LTP Induction
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Figure 6. Administering STEP Postsynaptically Prevents Induction of LTP at Schaffer Collateral CA1 Synapses
(A) Scatter plots of EPSP slope (upper graph) and simultaneously recorded fEPSP slope (lower graph) from individual representative experiments
with () or without () STEP in the whole-cell recording solution are shown. EPSP and fEPSP slopes were normalized to the average level
during the first 5 min of recording. Tetanus was delivered at time 0 min in this and all subsequent graphs. Each trace to the right of the plots
is the average of six consecutive EPSPs or fEPSPs recorded at the times indicated. Scale bars for this and all subsequent traces are 10 mV/
200 ms for EPSPs and 1 mV/20 ms for fEPSPs.
(B) The top graph is a plot of average EPSP slope versus time for experiments with (, n  6) or without (, n  8) active STEP included in
the whole-cell recording solution. The bottom graph shows the averaged slope of field EPSPs (fEPSPs) measured during experiments when
whole-cell recordings were done with () and without STEP ().
ment was increased by including 10 mM BAPTA in the that inhibiting endogenous STEP, either with a function-
blocking antibody or a dominant-inhibitory STEP mutantintracellular recording solution, administering anti-STEP
had no effect on AMPAR EPSPs (Figure 8B). Thus, the protein, increases NMDAR currents as expected for the
effects of inhibiting the endogenous PTP (Wang et al.,lasting potentiation of EPSPs produced by inhibiting
STEP does not occur through a direct effect on AMPA 1996; Wang and Salter, 1994). Both the depression of
NMDAR currents produced by STEP and the enhance-receptors, but rather is dependent upon NMDAR activa-
tion, Src-mediated upregulation of NMDAR function, ment of NMDAR currents by inhibiting STEP require the
activity of Src. Because we find that it is the 61 kDaand a rise in intracellular Ca2. From these results to-
gether, we conclude that STEP functions as a tonic isoform of STEP that coimmunoprecipitates with
NMDAR subunits, we conclude that STEP61 is an endog-brake on synaptic transmission at Schaffer collateral-
CA1 synapses by opposing Src-mediated enhancement enous PTP that regulates the function of NMDARs in
opposition to Src.of NMDARs, thus governing the induction of long-term
plastic changes in synaptic efficacy. A second main conclusion from our work is that ongo-
ing STEP-mediated depression of NMDAR activity toni-
cally regulates synaptic efficacy in CA1 hippocampalDiscussion
neurons: administering active recombinant STEP di-
rectly into CA1 neurons prevents the induction of LTPThe main goal achieved in the present work is the identi-
fication of an endogenous PTP that counterbalances by tetanic stimulation and, conversely, inhibiting endog-
enous STEP in these neurons enhances synaptic trans-the tyrosine kinase Src to regulate the function of
NMDARs. The principal requirements for such an endog- mission and occludes tetanus-induced LTP. Recent
models of NMDAR-dependent LTP postulate that theenous PTP, as inferred from previous studies (Wang et
al., 1996; Wang and Salter, 1994; Yu et al., 1997), are ultimate mechanism through which this form of plasticity
is expressed involves postsynaptic enhancement of thethat it must be intimately associated with the NMDAR
complex and must decrease the activity of NMDARs by channel activity and/or cell-surface expression of
AMPARs (Malenka and Nicoll, 1999; Malinow et al., 2000;opposing Src-mediated upregulation. Here, we find that
applying purified STEP depresses NMDAR currents in Soderling and Derkach, 2000). However, because these
receptors are not directly regulated by tyrosine phos-excised patches and at synapses. Conversely, we find
Neuron
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Figure 7. Inhibiting Endogenous STEP Enhances Synaptic Transmission and Occludes LTP at Schaffer Collateral CA1 Synapses
(A) Scatter plots of EPSP slope (upper graph) and simultaneously recorded fEPSP slope (lower graph) from individual experiments with ()
or without () anti-STEP in the whole-cell recording solution are shown. Each trace to the right of the plots is the average of six consecutive
EPSPs or fEPSPs recorded at the times indicated.
(B) The top graph is a plot of average EPSP slope versus time for experiments with (, n  9) or without (, n  8) anti-STEP included in the
whole-cell recording solution. The bottom graph shows averaged slope of field EPSPs (fEPSPs) measured during experiments when whole-
cell recordings were done with () and without anti-STEP ().
phorylation/dephosphorylation (Figures 2,3,5, and 8 and mediated rise in [Ca2]i. At first glance, these observa-
tions might appear contrary to the concept thatHuang et al., 2001; Lu et al., 1998; O’Dell et al., 1991), we
reason that STEP acts upstream of AMPARs. Initiation of NMDARs are said to be “blocked” at the resting mem-
brane potential by Mg2. However, even with physiologi-the LTP signaling cascade by tetanic stimulation re-
quires an acute increase in NMDAR function, such as cal concentrations of extracellular Mg2, the current
through NMDARs is not completely blocked at mem-that which may be brought about by suppressing Mg2
inhibition (Herron et al., 1986) or by activating Src (Ali and brane potentials near rest (MacDonald et al., 1982), al-
though this current is dramatically suppressed in com-Salter, 2001). Given that the enhancement of synaptic
transmission by inhibiting STEP is prevented by parison with depolarized potentials. Furthermore, recent
work demonstrates that synaptically activating NMDARsblocking NMDARs or the Src-dependent upregulation
of NMDARs, the most parsimonious explanation for our in CA1 neurons at the resting membrane potential pro-
duces Ca2 influx into dendritic spines (Kovalchuk et al.,results is that in CA1 neurons, STEP tonically sup-
presses NMDAR function and this suppression must be 2000). Our present findings indicate that inhibiting STEP
enhances pharmacologically isolated NMDAR EPSCsovercome in order to induce LTP.
When the anti-STEP antibody or the dominant-inhibi- recorded from neurons held near resting potential in the
presence of extracellular Mg2 (Figure 4). Therefore, thetor STEP mutant protein was administered into CA1
neurons, we found that EPSPs increased, even when rise in [Ca2]i produced within dendritic spines by EPSPs
at the resting potential would be increased by the en-the frequency of synaptic stimulation was low. We have
previously shown that synaptic AMPAR responses are hancement of NMDAR function produced by inhibiting
STEP and may thus bypass the requirement for tetanicsimilarly potentiated by intracellularly administering ex-
ogenous Src, a Src-activating peptide (Lu et al., 1998), stimulation to trigger LTP induction. It is unlikely that
inhibiting STEP causes suppression of Mg2 inhibitionor the Src-activating kinase CAK/Pyk2 (Huang et al.,
2001). As with the presently reported effects of anti- because the enhancement of NMDAR EPSCs by inhib-
iting STEP did not alter the NMDAR current-voltage rela-STEP, the potentiation of AMPAR responses induced
by Src kinase, or its activators, is prevented by blocking tionship. It is possible, however, that inhibiting STEP
may additionally act by facilitating processes down-NMDARs or by strongly buffering intracellular Ca2. In
contrast, strongly buffering Ca2 does not prevent the stream of, or in parallel to, Ca2 entry through NMDARs
that contribute to enhancement of AMPAR responses.enhancement of NMDAR currents by anti-STEP or by
Src. Together these results imply that the potentiation Our present findings indicate that the range over
which NMDAR currents are regulated by activating orof AMPAR responses is dependent upon an NMDAR-
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PTPMEG (Hironaka et al., 2000), have been reported to
co-precipitate with NMDARs, but the effects of these
PTPs on NMDAR function are unknown. PTPMEG is
reported to promote Fyn-dependent phosphorylation of
the GluRepsilon1 (NR2A) subunit (Hironaka et al., 2000),
thus it seems unlikely that this phosphatase depresses
NMDAR function since Fyn has been demonstrated to
upregulate currents mediated by recombinant NMDARs
expressed in HEK293 cells (Kohr and Seeburg, 1996).
For PTP1D, or other PTPs that might also associate
with NMDARs, while it is conceivable that these might
participate in downregulating NMDAR channel activity,
our results indicate that such effects would be depen-
dent upon STEP in CA1 and dorsal horn neurons. Alter-
native, or additional, functional roles for these PTPs
might be in processes other than modulating NMDAR
channel activity, such as in regulating NMDAR targeting
or trafficking (Dunah and Standaert, 2001; Vissel et al.,
2001). Whether, in other cell types, there are PTP(s) that
are able to subserve the same function as STEP does in
CA1 and dorsal horn neurons remains to be determined.
Regulation of NMDAR function is critical to the devel-
opment, maintenance, and plasticity of synaptic con-
tacts (Dingledine et al., 1999; McBain and Mayer, 1994).
Therefore, identification of specific proteins and pro-
cesses that modulate NMDA channel function may be
crucial in understanding the mechanisms by which syn-
aptic transmission is controlled. Our results indicate that
NMDAR-associated STEP tonically depresses channel
activity to regulate synaptic efficacy. Because STEP is
expressed in various regions of the nervous system
(Boulanger et al., 1995) and tyrosine phosphorylation
has been implicated in synaptic plasticity in a number
of CNS areas (Boxall et al., 1996; Rosenblum et al., 1996,
1997; Rostas et al., 1996), we expect that this role of
STEP may be a common mechanism for regulating excit-
atory synaptic transmission in many regions of the CNS.
Experimental Procedures
Coimmunoprecipitation of STEP and NMDARs
Striatal and hippocampal homogenates were prepared from male
Figure 8. Enhancement of EPSPs by STEP Inhibition Requires adult rats. The tissue was homogenized in 10 vol of ice-cold HEPES-
NMDARs, Src Activity, and Ca2 buffered sucrose (0.32 M sucrose, 4 mM HEPES, 1 mM sodium
(A) Scatter plots of EPSP slope (upper graph) and simultaneously orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 2 g/ml pep-
recorded fEPSP slope (lower graph) from individual experiments statin A, 2 g/ml leupeptin, and 2 g/ml aprotinin, pH 7.4) and
with anti-STEP in the recording solution in the absence () or pres- centrifuged at 800	 g for 10 min at 4
C to remove nonhomogenized
ence () of MK801 (1 M) and in the presence of Src 40-58 (0.03 material (Paul et al., 2000). Crude synaptosomes were prepared
mg/ml; ) are shown. Each trace on the right is the average of six from the striatum of male adult rats according to methods used for
consecutive EPSPs/fEPSPs recorded at the times indicated. Note whole forebrain as described elsewhere (Huang et al., 2001). Fetal
that the data plotted for anti-STEP alone are from a different cell spinal cord membranes were prepared by methods adapted from
than that used for Figure 6A. Sheng et al. (1992). The spinal cords were homogenized in ice-cold
(B) A summary bar graph displaying the mean normalized EPSP Tris buffer (50 mM tris-HCl, 1 mM sodium orthovanadate, 1 mM
slope 20 min after breakthrough in neurons recorded with control phenylmethylsulfonyl fluoride, 20 g/ml pepstatin A, 20 g/ml leu-
ICS (control, n  8), C300S STEP containing ICS (C300S STEP, n  peptin, and 20g/ml aprotinin, pH 7.4) and centrifuged at 270	 g for
4), anti-STEP containing ICS (anti-STEP, n  9), anti-STEP con- 10 min at 4
C to remove debris. Immunoprecipitation of membrane
taining ICS with MK801 in the bathing solution (MK801, n  4), proteins under nondenaturing and denaturing conditions was per-
ICS supplemented with both anti-STEP and Src 40-58 (Src 40-58, formed as previously described (Yu et al., 1997). For nondenaturing
n 4), or ICS supplemented with both anti-STEP and 10 mM BAPTA conditions, fetal membrane proteins were solubilized in ice-cold 50
(BAPTA, n  7) is shown. (*p  0.05, **p  0.01, t test versus ICS.) mM tris-HCl (pH 7.6) containing 150 mM NaCl, 1% igepal ca630,
0.5% deoxycholate, 0.1% SDS, 1 mM orthovanadate, and the prote-
ase inhibitors pepstatin A (20 g/ml), leupeptin (20 g/ml), aprotinin
(20g/ml), and phenylmethylsulfonyl fluoride (1 mM). For denaturinginhibiting STEP matches that produced by inhibiting or
conditions, membrane proteins were boiled in 1% SDS followed by
activating Src, respectively. Thus, STEP appears to ac- 5-fold dilution with 50 mM tris-HCl (pH 7.6) containing 190 mM NaCl,
count for the PTP activity opposing Src. Other PTPs, 1.25% Triton X-100, 1 mM sodium orthovanadate, 6 mM EDTA, and
the protease inhibitors listed above. Solubilized proteins (300 g)namely PTP1D (Husi et al., 2000; Lin et al., 1999) and
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were centrifuged at 14,000 	 g to remove insoluble material and with 1% Triton X-100, pH 6.2, with 1.9 mM pNPP for 30 min at 30
C,
and the reactions were terminated by adding 900 l of 0.2N NaOH.then incubated with anti-NR1(5 g), anti-STEP (1/500 dilution), anti-
GluR2 (5 g), or nonspecific IgG (5 g) overnight at 4
C. Immune The production of paranitrophenolate ion was expressed as a con-
centration using a molar extinction coefficient of 1.78 	 104 M1complexes were isolated by adding 50 l of protein G-Sepharose
beads and incubating for 1 hr at 4
C. Immunoprecipitates were cm1 at 410 nm. The activities of recombinant STEP46-GST or trun-
cated T cell phosphatase (Calbiochem, La Jolla, CA) were measuredwashed five times with lysis buffer and resuspended in 2	 Laemmli
sample buffer and boiled for 5 min. The samples were then subjected with or without a 4-fold excess of anti-STEP antibody or with a
nonspecific IgG (Figure 3A2 inset). The Kcat for STEP was decreasedto SDS-polyacrylamide gel electorphoresis (SDS-PAGE) (10% gel)
and then transferred to nitrocellulose membranes which were from 213  13 mole/mole/min (mean  SEM, n  6) to 30  1.7
mole/mole/min (n  3; p  0.01, t test) with anti-STEP. In contrast,probed with anti-NR1 (0.5 g/ml), anti-STEP (1/1000), or anti-GluR2
(1 g/ml). the activity of truncated T cell phosphatase was not affected by the
anti-STEP antibody: Kcat  control, 3360  220 mole/mole/min, n 
3; with anti-STEP, 3433 217, n 3 (p 0.1). In other experiments,Single-Channel Patch-Clamp Recordings
from Cultured Neurons we tested anti-STEP on the activity of PTP-1B (Calbiochem, La Jolla,
CA). The Kcat for PTP1B was unaffected by the antibody: 1818  62Primary cultures of spinal dorsal horn were prepared from fetal
Wistar rats (embryonic day 17–18) (Salter and Hicks, 1994). Briefly, mole/mole/min (n  4) without versus 1750  29 mole/mole/min
with anti-STEP (n  3) .the spinal cord was removed from each fetus, and the dorsal half
of the cord was dissected. Dorsal horn cells were isolated and plated
in MEM supplemented with 10% FBS, 10% heat-inactivated horse Hippocampal Slice Recordings
serum, and 1 U/ml insulin. Cultures were used 10–24 days after Acute hippocampal slices were prepared from 4- to 6-week-old
plating. Media and sera were from Life Technologies (Burlington, male Sprague Dawley rats and were placed in a holding chamber
Ontario, Canada). Single-channel recordings and analyses from in- for at least 1 hr prior to recording (Lu et al., 1998). A single slice was
side-out patches are described by Yu et al., 1997. Cultures were transferred to a recording chamber and superfused with artificial
bathed in extracellular solution containing (in mM): 80 Na2SO4, 10 cerebral spinal fluid (ACSF, 2 ml/min) composed of (in mM): 124
Cs2SO4, 25 HEPES, 1.3 CaCl2, 33 glucose, 0.003 glycine, and 0.001 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 26 NaHCO3, 10
tetrodotoxin, pH 7.35 (310–325 mOsm). NMDA channel activity was
D-glucose, 0.005 bicuculline methiodide, saturated with 95%O2—
evoked by including 0.01 mM NMDA in the extracellular solution 5%CO2 at 30
C 2
C (pH 7.35; 310–320 mOsm). Synaptic responses
contained within patch pipettes. Once a patch was pulled from the were evoked with bipolar tungsten electrodes placed approximately
cell, the tip of the recording pipette was removed to a small reservoir 50 m from the cell body layer in CA1. Test stimuli were delivered at
where the intracellular aspect of the patch was perfused with intra- 0.1 Hz with the stimulus intensity set to 25% of that which produced
cellular solution composed of (in mM): 140 CsCl, 10 HEPES, 1 CaCl2, maximum synaptic responses. Tetanic stimulation consisted of two
10 BAPTA, 2 MgCl2, 4 K2-ATP, pH 7.25 (310–325 mOsm) supple- trains of 100 Hz stimuli lasting 500 ms, with an intertrain interval of
mented where indicated with recombinant STEP46-GST (5 g/ml). 10 s. In controls, this stimulation caused LTP that was at a stable
Patches were held at 70 mV and current records were stored on level by 30 min after tetanus and which persisted for greater than
tape. For analysis, recordings were replayed, filtered at 2 kHz, and 1 hr. For clarity of presentation, we show records from only the first
sampled at 20 kHz onto a computer using the fetchex program 30 min after tetanic stimulation. EPSP slope was calculated as the
of the pClamp7 suite (Axon Instruments). Channel openings and slope of the rising phase 10%–65% of the peak response. Field
closings were determined using the 50% crossing threshold potential recordings were made with glass micropipettes filled with
method. Channel activity during a control period 4–7 min immedi- ACSF placed in the stratum radiatum 60–80 m from the cell body
ately preceding enzyme application was compared with activity dur- layer and 100–150 m from the site of whole-cell recording. Field
ing a similar period beginning 1–2 min after the start of the appli- EPSP slope was calculated as the slope of the rising phase between
cation. 10% and 60% of the peak response. For current-clamp experiments,
the patch pipette (4–6 M) solution contained 132.5 mM K-gluco-
Miniature EPSC Recordings nate, 17.5 mM KCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM Mg-ATP,
Methods for whole-cell recordings are described by Wang et al. 0.3 mM GTP, and 5 mM QX 314 (pH 7.25, 290 mOsm); EGTA was
(1996). Cultures were bathed in extracellular solution containing (in replaced with BAPTA (10 mM) where indicated. For voltage-clamp
mM): 140 NaCl, 5.4 KCl, 25 HEPES, 1.3 CaCl2, 33 glucose, 0.001 experiments, the intracellular solution contained: 132 mM Cs-gluco-
glycine, 0.001 tetrodotoxin, 0.01 bicuculline, 0.01 strychnine, pH nate, 17 mM CsCl, 10 mM HEPES, 10 mM BAPTA, 2 mM Mg-ATP, 0.3
7.35 (310–320 mOsm). The extracellular solution was supplemented mM GTP, and 5 mM QX 314 (pH 7.25, 290 mOsm). The intracellular
where indicated with 50 nM PP2 or PP3 (Calbiochem, La Jolla, CA) solutions were supplemented as required with recombinant STEP,
or 0.05 mM AP5 (Sigma). Patch electrodes (4–7 M) were filled with anti-STEP antibody, IgG, C300S STEP, and Src 40-58 that were
intracellular solution containing (in mM): 140 CsCl, 10 HEPES, 10 stored as single use stock solutions prepared just before use. Te-
BAPTA, 2 Mg-ATP, pH 7.25 (300–310 mOsm). The intracellular solu- tanic stimulation was delivered after 20 min of whole-cell recording.
tion was supplemented as required with STEP46-GST (5 g/ml), mu- EPSP and fEPSP slopes were normalized to the respective average
tant C300S STEP46-GST (5 g/ml), anti-STEP antibody (23E5) (1:200 level during the first 5 min of whole-cell recording. Patch recordings
dilution), or nonspecific immunoglobulin G (IgG) antibody (1:200
were done using the “blind” patch method (Blanton et al., 1989).
dilution) and the osmolarity was readjusted accordingly. Membrane
For recording NMDAR-mediated synaptic responses, ACSF was
potential was held constant at 60 mV and whole-cell currents
supplemented with DNQX (5 M) and neurons were held at 60
were recorded using an Axopatch 200B amplifier (Axon Instruments,
mV. NMDAR-mediated EPSC peak ampitudes were normalized to
Foster City, CA). Miniature EPSCs were recorded immediately upon
the first 2 min of whole-cell recording. Current-voltage relationships
formation of the whole-cell patch configuration and continuously
for NMDA EPSCs were performed at the end of each recording andmonitored for 20–30 min thereafter. Miniature EPSCs were filtered
EPSC amplitude at each membrane potential was normalized on aat 2 kHz and acquired online with a personal computer using Strath-
cell-by-cell basis to that of the EPSC obtained at a holding potentialclyde software (courtesy of J. Dempster) with the detection level
of 40 mV. Raw data were amplified using an Axopatch 1-D, sam-set to approximately three times higher than the baseline noise.
pled at 10 kHz, and analyzed with Pclamp software (Axon Instru-False events and traces with more than 1 event per 200 ms recording
ments, Foster City, CA). Series resistance ranged from 10 to 30 Mperiod were eliminated by subsequent inspection of the raw data,
and cells were discarded if the resistance changed by more than 15%.and averages were created using a minimum of 30 traces aligned
by their rising edges. All recordings from cultured neurons were
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